Analysts tracking Ocugen Inc. are projecting cautious optimism for "ocgn stock forecast 2025", with revenue growth hinging on pipeline advancements in gene therapy and ophthalmic trials. Current market capitalization hovers near $500M, but volatility remains high due to biotech sector sentiment. Investors should watch quarterly earnings for catalysts. Companies discussed in this article include NasdaqCM:OCGN NasdaqGM:CMPO and NasdaqGS:HUMA . Be the first to see our newest insights and key updates across all datasets Technical patterns suggest "ocgn stock forecast 2025" may find strong support near $3.